|
Volumn 113, Issue 4, 2001, Pages 846-
|
Acute cerebellar syndrome following intermediate-dose cytarabine
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DEXAMETHASONE;
DOXORUBICIN;
GADOLINIUM;
PREDNISONE;
VINCRISTINE;
ACUTE CEREBELLAR SYNDROME;
ADULT;
ARTICLE;
ATAXIA;
B CELL LYMPHOMA;
CASE REPORT;
CEREBELLUM DISEASE;
CLINICAL FEATURE;
DIAGNOSTIC IMAGING;
DIAGNOSTIC PROCEDURE;
DISEASE COURSE;
DYSARTHRIA;
HUMAN;
LARGE CELL LYMPHOMA;
MOTOR COORDINATION;
NEUROTOXICITY;
NONHODGKIN LYMPHOMA;
NUCLEAR MAGNETIC RESONANCE IMAGING;
NYSTAGMUS;
PRIORITY JOURNAL;
RISK FACTOR;
TREATMENT OUTCOME;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ATAXIA;
BRAIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DEXAMETHASONE;
DOXORUBICIN;
DYSARTHRIA;
GAIT ATAXIA;
HUMANS;
LYMPHOMA, B-CELL;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
NYSTAGMUS, PATHOLOGIC;
PREDNISONE;
SYNDROME;
VINCRISTINE;
|
EID: 0034932447
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2001.02771.x Document Type: Article |
Times cited : (13)
|
References (0)
|